Clinical Trials

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio

Pancreatic Cancer


Temozolomide and Pazopanib Hydrochloride for Pancreatic Cancer
A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET)

Investigator: Gabriela Chiorean, MD;   Conditions: Pancreatic Cancer;    Status: Recruiting;   Study ID: NCT01465659

MPDL3280A + Cobimetinib for Locally Advanced or Metastatic Cancer
A Phase 1b Study of the Safety and Pharmacology of MPDL3280A Administered With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors

Investigator: Laura Chow, MD;   Conditions: Neoplasms;    Status: Recruiting;   Study ID: NCT01988896

Veliparib for Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib in Subjects With Solid Tumors

Investigator: Elizabeth Swisher, MD;   Conditions: High Grade Serous Ovarian Cancer, BRCA Mutated Breast Cancer;    Status: Closed;   Study ID: NCT01853306